- Home
- TNGX vs RDVT Comparison
TNGX vs RDVT Comparison
Compare TNGX & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- RDVT
- Stock Information
- Founded
- TNGX 2014
- RDVT 2017
- Country
- TNGX United States
- RDVT United States
- Employees
- TNGX N/A
- RDVT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- RDVT Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- RDVT Technology
- Exchange
- TNGX Nasdaq
- RDVT Nasdaq
- Market Cap
- TNGX 723.0M
- RDVT 649.4M
- IPO Year
- TNGX N/A
- RDVT N/A
- Fundamental
- Price
- TNGX $6.53
- RDVT $42.38
- Analyst Decision
- TNGX Strong Buy
- RDVT
- Analyst Count
- TNGX 5
- RDVT 0
- Target Price
- TNGX $10.50
- RDVT N/A
- AVG Volume (30 Days)
- TNGX 1.9M
- RDVT 79.6K
- Earning Date
- TNGX 08-05-2025
- RDVT 08-06-2025
- Dividend Yield
- TNGX N/A
- RDVT 0.70%
- EPS Growth
- TNGX N/A
- RDVT N/A
- EPS
- TNGX N/A
- RDVT 0.61
- Revenue
- TNGX $40,990,000.00
- RDVT $79,681,000.00
- Revenue This Year
- TNGX N/A
- RDVT $18.86
- Revenue Next Year
- TNGX N/A
- RDVT $13.99
- P/E Ratio
- TNGX N/A
- RDVT $70.23
- Revenue Growth
- TNGX 10.09
- RDVT 26.30
- 52 Week Low
- TNGX $1.03
- RDVT $3.03
- 52 Week High
- TNGX $12.02
- RDVT $52.24
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- RDVT 31.85
- Support Level
- TNGX $6.36
- RDVT $44.08
- Resistance Level
- TNGX $7.11
- RDVT $45.32
- Average True Range (ATR)
- TNGX 0.52
- RDVT 1.24
- MACD
- TNGX -0.13
- RDVT -0.29
- Stochastic Oscillator
- TNGX 53.15
- RDVT 3.92
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.